[1] 张存,季祥武.巨噬细胞游走抑制因子的研究进展[J].中国循证心血管医学杂志,2014,6(6):778-780.[2] Flaster H, Bernhagen J, Calandra T, et al. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol. 2007;21(6): 1267-1280.[3] Fukaya R, Ohta S, Yaguchi T, et al. MIF maintains the tumorigenic capacity of brain tumor-initiating cells by directly inhibiting p53. Cancer Res. 2016;76(9):2813-2823.[4] Wang H, Yang Z, Liu C, et al. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway. Biochem Biophys Res Commun. 2014; 454(1):71-77.[5] Miller EJ, Li J, Leng L, et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature. 2008;451(7178):578-582.[6] Atsumi T, Cho YR, Leng L, et al. The Proinflammatory Cytokine Macrophage Migration Inhibitory Factor Regulates Glucose Metabolism during Systemic Inflammation. J Immunol. 2007;179(8):5399-5406.[7] Guo X, Xu S, Gao X, et al. Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells. Oncotarget. 2017;8(46):80358-80372.[8] Aeberli D, Leech M, Morand EF. Macrophage migration inhibitory factor and glucocorticoid sensitivity. Rheumatology. 2006;45(8):937-943.[9] 吴杰,黄承滨,赵育桢,等.MIF基因多态性及其与疾病关系的研究进展[J].国际遗传学杂志,2009,32(2):115-119.[10] Baugh JA, Chitnis S, Donnelly SC, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immunity. 2002;3(3):170.[11] De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2003;48(5):1398-1407.[12] Lehmann LE, Book M, Hartmann W, et al. A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. J Transl Med. 2009;7(1):100.[13] Wu J, Fu S, Ren X, et al. Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population. HLA. 2009;73(4):302-306.[14] Wang FF, Huang XF, Shen N, et al. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease. Arthritis Res Ther. 2013;15(3):R65.[15] Savva A, Brouwer MC, Roger T, et al. Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis. Proc Natl Acad Sci U S A. 2016;113(13): 3597-3602.[16] Kuai SG, Ou QF, You DH, et al. Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis. Infect Dis. 2015;48(3):1.[17] 方芳,陈伟英.巨噬细胞游走抑制因子在人体炎症反应中的作用及其机制[J].国际内科学杂志,2004,31(5):210-213.[18] 柳爱华,石梅,赵勤,等.MIF基因启动子多态性与结核病相关性研究进展[J].热带医学杂志,2010,10(9):1143-1145.[19] Liu R, Xu N, Wang X, et al. Influence of MIF , CD40 , and CD226 polymorphisms on risk of rheumatoid arthritis. Mol Biol Rep. 2012;39(6):6915-6922.[20] 严瀚,周汉成,刘恩志,等.类风湿关节炎滑膜中巨噬细胞游走抑制因子的表达及意义[J].临床和实验医学杂志, 2013,12(9): 651-653.[21] Santos LL, Morand EF. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta. 2009;399(1-2):1-7.[22] 奚正德,席晔斌,葛海良.巨噬细胞游走抑制因子在自身免疫性和炎症性疾病中的关键作用[J].国际免疫学杂志, 2011,34(5): 249-252.[23] 杜雪霞,陈宝峰,邓芸,等.巨噬细胞游走抑制因子与2型糖尿病合并大血管病的关系研究[J].疑难病杂志,2015,15(1):29-32.[24] Gong Z, Xing S, Zheng F, et al. Increased expression of macrophage migration inhibitory factor in aorta of patients with coronary atherosclerosis. J Cardiovasc Surg. 2014;56(4): 631-637.[25] 杨林承,祖凌云,高炜.巨噬细胞游走抑制因子在冠心病诊断及治疗中的价值[J].中国心血管杂志,2015,20(5):382-384.[26] 徐锐,杨毅宁,马依彤,等.巨噬细胞游走抑制因子基因rs1007888位点单核苷酸多态性与哈萨克族冠状动脉粥样硬化性心脏病发病的相关性[J].中国组织工程研究, 2015,19(2):231-235.[27] Hoi AY, Hickey MJ, Hall P, et al. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. J Immunol. 2006;177(8):5687.[28] Park HK, Cho MK, Park HY, et al. Macrophage migration inhibitory factor isolated from a parasite inhibited Th2 cytokine production in PBMCs of atopic asthma patients. J Asthma. 2012;49(1):10-15.[29] Chen PF, Luo YL, Wang W, et al. ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med. 2010;16(9-10):400.[30] Falvey JD, Bentley RW, Merriman TR, et al. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. World J Gastroenterol. 2013;19(39):6656-6664.[31] Nishihira J. Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease. Ann N Y Acad Sci USA. 2012;1271(1):53.[32] Xia HX, Zhang ST, Lam SK, et al. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs. Carcinogenesis. 2005;26(1):11-15.[33] Shiroeda H, Tahara T, Shibata T, et al. Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases. Int J Mol Med. 2010;26(5):707-711.[34] Fehlings M, Drobbe L, Moos V, et al. Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect Immun. 2012; 80(8):2724-2734.[35] 沈媛媛,王爱丽,程凯,等.MIF抗体对大肠癌癌前病变及大肠癌MIF、VEGF、PDGF表达的影响[J].胃肠病学和肝病学杂志, 2017,26(8):869-872.[36] Han Y, Zhang C. Macrophage migration inhibitory factor plays a pivotal role in hepatocellular carcinoma and may be a noninvasive imaging target. Med Hypotheses. 2010;75(6): 530-532.[37] Jin ZQ, Zhi FC, Chen XQ, et al. Expression of macrophage migration inhibition factor in pancreatic carcinoma tissue. Di Yi Jun Yi Da Xue Xue Bao. 2004;24(11):1301-1303.[38] Javeed A, Zhao Y, Zhao Y. Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection. Inflamm Res. 2008;57(2):45-50.[39] Calandra T, Echtenacher B, Roy DL, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Medicine. 2000;6(2):164-170.[40] 詹芝娅,方向明.巨噬细胞游走抑制因子与脓毒血症[J].中国医师杂志,2006,8(1):141-142.[41] Pan X, Xin M, Tao C, et al. Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo. Mol Cell Biochem. 2011;357(1-2):313-321.[42] Baron N, Deuster O, Noelker C, et al. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. J Neurosci Res. 2011;89(5):711-717.[43] 文怡,黄金燕,钟振东,等.MIF表达与子宫内膜异位症血瘀证的相关性研究[J].南京中医药大学学报,2013,29(2):132-134.[44] Cheng RJ, Deng WG, Niu CB, et al. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma. Int J Gynecol Cancer. 2011;21(6): 1004-1012.[45] Viganò P, Cintorino M, Schatz F, et al. The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface. Semin Immunopathol. 2007;29(2):135-150.[46] 马蕾,张玉杰.巨噬细胞游走抑制因子与皮肤病[J].滨州医学院学报,2010,33(2):134-136.[47] Zis O, Zhang S, Dorovini-Zis K, et al. Hypoxia Signaling Regulates Macrophage Migration Inhibitory Factor (MIF) Expression in Stroke. Mol Neurobiol. 2015;51(1):155-167.[48] Lan MY, Chang YY, Chen WH, et al. Association between MIF gene polymorphisms and carotid artery atherosclerosis. Biochem Biophys Res Commun. 2013;435(2):319-322.[49] 陈宝友,李强,刘爱,等.脑出血患者血清中一氧化氮、胰岛素样生长因子-1和巨噬细胞转移抑制因子的表达水平及意义[J].中国老年学杂志,2015,35(7):1750-1751.[50] Bloom J, Alabed Y. MIF: Mood Improving/Inhibiting Factor? J Neuroinflammation. 2014;11(1):11.[51] Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest. 2009;119(4):717-725.[52] 李延仓,娄石磊.烧伤康复期老年患者抑郁评分与血清中BDNF、MIF和Cor的关系探讨[J].医学理论与实践,2015,28(8): 1025-1026.[53] Conboy L, Varea E, Castro JE, et al. Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors. Mol Psychiatry. 2011;16(5):533-547. [54] Popp J. P3-372: Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. J Psychiatr Res. 2009;43(8):749-753.[55] Flex A, Giovannini S, Biscetti F, et al. Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease. Neurodegener Dis. 2014;13(4):230-236.[56] 韩冰莎,王丽娟,赵洁皓,等.阿尔茨海默病患者外周血巨噬细胞游走抑制因子的表达[J].中国神经精神疾病杂志,2008,34(4): 201-204.[57] Rebecca CS, Max K, Xiong C, et al. Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis. PLoS One. 2011;6(4):e18850.[58] Oyama R, Yamamoto H, Titani K. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation. Biochimica Et Biophysica Acta. 2000;1479(1-2):91. |